A review of the latest research on M pro targeting SARS-COV inhibitors

H Yang, J Yang - RSC medicinal chemistry, 2021 - pubs.rsc.org
… of SARS-COV-2 M pro inhibitors. Like SARS-COV-1, SARS-COV-2 M pro inhibitors can be
… , and the mechanism of action of peptide inhibitors includes two steps. Peptidomimetics that …

[HTML][HTML] Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Z Jin, X Du, Y Xu, Y Deng, M Liu, Y Zhao, B Zhang, X Li… - Nature, 2020 - nature.com
… The structure of SARS-CoV-2 M pro in complex with N3 provides a model for identifying lead
inhibitors to target SARS-CoV-2 M pro using in silico screening. To achieve this, we docked …

Advances in the development of SARS-CoV-2 Mpro inhibitors

L Agost-Beltrán, S de la Hoz-Rodríguez, L Bou-Iserte… - Molecules, 2022 - mdpi.com
… The cleavage site of Mpro is between a glutamine at the P1 site and a small residue at P1′…
for inhibitors of SARS-CoV-2 Mpro. We will focus on the SARS-CoV-2 Mpro inhibitors that …

Potential SARS-CoV-2 main protease inhibitors

R Banerjee, L Perera, LMV Tillekeratne - Drug Discovery Today, 2021 - Elsevier
inhibitors. With the recent reporting of the X-ray crystal structure of the SARS-CoV-2 M pro ,
studies to discover M pro inhibitors … -molecule inhibitors targeting the SARS-CoV-2 M pro . …

SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model

J Qiao, YS Li, R Zeng, FL Liu, RH Luo, C Huang… - Science, 2021 - science.org
… Here, we describe the design of 32 new SARS-CoV-2 M pro inhibitors, two of which show …
structures of SARS-CoV-2 M pro (11–13) and our cocrystal structures of SARS-CoV-2 M pro in …

The SARSCoV‐2 main protease (Mpro): Structure, function, and emerging therapies for COVID‐19

Q Hu, Y Xiong, GH Zhu, YN Zhang, YW Zhang… - MedComm, 2022 - Wiley Online Library
… Thus, this review focuses on the structural features and function of 3CL pro and recent
advances in the discovery of SARS-CoV-2 3CL pro inhibitors, aiming to provide a SARS-…

An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19

DR Owen, CMN Allerton, AS Anderson… - Science, 2021 - science.org
… of an M pro inhibitor in a transgenic mouse model of SARS-CoV-2 infection (16). Given the
pivotal role of SARS-CoV-2 M pro in … challenges, SARS-CoV-2 M pro inhibition represents an …

Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay

A Narayanan, M Narwal, SA Majowicz… - Communications …, 2022 - nature.com
… cysteine residue of Mpro for blocking … inhibitors of Mpro and PLpro significantly reduce
SARS-CoV-2, and can be used in combination for an enhanced antiviral effect. Protease inhibitors

SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging

W Rut, K Groborz, L Zhang, X Sun… - Nature chemical …, 2021 - nature.com
… that SARS-CoV M pro and SARS-CoV-2 M pro exhibit … the SARS-CoV main proteases as
well as tetrapeptide inhibitors. Further, we present a crystal structure of the SARS-CoV-2 M pro

SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors

A Citarella, A Scala, A Piperno, N Micale - Biomolecules, 2021 - mdpi.com
… of selectively inhibiting the SARS-CoV-2 M pro activity have been … inhibition. Therefore, this
review is focused on the structure of the SARS-CoV-2 M pro and the discovery of its inhibitors